Usha Chakravarthy

Usha Chakravarthy

Belfast, NIR, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 288 publications

Use of Fellow Eyes as Controls in Clinical Trials-Reply.

Use of Fellow Eyes as Controls in Clinical Trials-Reply.

Journal: JAMA ophthalmology

Published: August 13, 2026

Do OCTA morphological patterns in neovascular AMD actually matter? A scoping review of clinical utility and terminological overlap.

Do OCTA morphological patterns in neovascular AMD actually matter? A scoping review of clinical utility and terminological overlap.

Journal: Retina (Philadelphia, Pa.)

Published: July 27, 2026

Predicting risk of progression of early to late AMD in the aging eye through imaging and multimodal evaluation: PRIME study protocol.

Predicting risk of progression of early to late AMD in the aging eye through imaging and multimodal evaluation: PRIME study protocol.

Journal: PloS one

Published: July 23, 2026

Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).

Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR).

Journal: BMJ (Clinical research ed.)

Published: June 18, 2026

Spectrally Resolved Fundus Autofluorescence as a Biomarker of Retinal Metabolic Integrity in Intermediate and Atrophic AMD.

Spectrally Resolved Fundus Autofluorescence as a Biomarker of Retinal Metabolic Integrity in Intermediate and Atrophic AMD.

Journal: Investigative ophthalmology & visual science

Published: May 14, 2026

Modest and Variable Correlations Between Geographic Atrophy Enlargement Rates in Fellow Eyes in the AREDS2 Study.

Modest and Variable Correlations Between Geographic Atrophy Enlargement Rates in Fellow Eyes in the AREDS2 Study.

Journal: JAMA ophthalmology

Published: April 02, 2026

Modest and Variable Correlations Between Geographic Atrophy Enlargement Rates in Fellow Eyes in the AREDS2 Study.

Modest and Variable Correlations Between Geographic Atrophy Enlargement Rates in Fellow Eyes in the AREDS2 Study.

Journal: JAMA ophthalmology

Published: April 02, 2026

Infographic: impact of baseline visual acuity, time-in-range and early treatment on functional outcomes in DMO: insights from the IRISS outcomes.

Infographic: impact of baseline visual acuity, time-in-range and early treatment on functional outcomes in DMO: insights from the IRISS outcomes.

Journal: Eye (London, England)

Published: March 30, 2026

Retinal pigment epithelial detachment: Molecular mechanisms, multimodal imaging classification, and clinical management across the spectrum of macular disease.

Retinal pigment epithelial detachment: Molecular mechanisms, multimodal imaging classification, and clinical management across the spectrum of macular disease.

Journal: Progress in retinal and eye research

Published: March 14, 2026

Structure-Function Correlations Using Artificial Intelligence-Extracted Retinal Layer Attenuation Measurements in OCT in Eyes with Geographic Atrophy.

Structure-Function Correlations Using Artificial Intelligence-Extracted Retinal Layer Attenuation Measurements in OCT in Eyes with Geographic Atrophy.

Journal: Ophthalmology science

Published: February 02, 2026

Correction: Artificial intelligence-based analysis of retinal fluid volume dynamics in neovascular age-related macular degeneration and association with vision and atrophy.

Correction: Artificial intelligence-based analysis of retinal fluid volume dynamics in neovascular age-related macular degeneration and association with vision and atrophy.

Journal: Eye (London, England)

Published: January 21, 2026

Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway Trial.

Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway Trial.

Journal: Ophthalmology science

Published: December 03, 2025

Showing 1-12 of 288

Last Updated: 09/26/2026